Education
About Us
Working with TipRanks
Follow Us
Xilio Therapeutics (XLO)
NASDAQ:XLO
Xilio Therapeutics (XLO) Ownership Overview
18.26% Insiders
2.93% Mutual Funds
1.29% Other Institutional Investors
2.22% ETFs
75.30% Public Companies and
Individual Investors
The ownership structure of Xilio Therapeutics (XLO) stock is a mix of institutional, retail, and individual investors. Approximately 6.44% of the company’s stock is owned by Institutional Investors, 18.26% is owned by Insiders, and 75.30% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 18, 2025 | xxxxxxxxxxxxx | $24677 | |
Jun 18, 2025 | xxxxxxxxxxxxx | $47600 | |
Dec 19, 2024 | xxxxxxxxxxxxx | $1830377 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,105,451 | Insider | 17.58% | 6,492,187 | |
| 1,148,079 | Institution | 2.22% | 818,580 | |
| 1,132,772 | Institution | 2.19% | 807,666 | |
| 311,639 | Institution | 0.60% | 222,199 | |
| 281,172 | Insider | 0.54% | 200,476 | |
| 71,081 | Institution | 0.14% | 50,681 | |
| 70,000 | Insider | 0.14% | 49,910 | |
| 1,107 | Institution | <0.01% | 789 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,132,772 | Institution | 2.19% | 807,666 | |
| 311,639 | Institution | 0.60% | 222,199 | |
| 71,081 | Institution | 0.14% | 50,681 | |
| 1,107 | Institution | <0.01% | 789 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 739,563 | Institution | 1.43% | 791,332 | |
| 408,516 | Institution | 0.79% | 437,112 |
FAQ
Who Owns Xilio Therapeutics (XLO)?
According to the latest TipRanks data, approximately 1.29% of the company's stock is held by institutional investors, 18.26% is held by insiders, and 75.30% is held by retail investors.
What percentage of Xilio Therapeutics (XLO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.29% of Xilio Therapeutics (XLO) stock is held by institutional investors.
What percentage of Xilio Therapeutics (XLO) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.30% of Xilio Therapeutics (XLO) stock is held by retail investors.
Who owns the most shares of Xilio Therapeutics (XLO)?
Gilead Sciences Inc owns the most shares of Xilio Therapeutics (XLO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.